Somer Baburek: Endometriosis Enters a New Phase as Science and Awareness Converge
Somer Baburek, Co-Founder, CEO, President at Hera Biotech, shared a post on LinkedIn:
“Over the past few months, several developments in endometriosis research have pointed to a broader shift in the field.
Taken individually, each is interesting.
Taken together, they suggest something more significant.
We’re beginning to see the early stages of a transformation in how endometriosis is understood, diagnosed, and ultimately treated.
On one hand, recent genomic research is starting to clarify the biological origin of endometriosis lesions, suggesting they may be derived from endometrial tissue.
On the other, the new ACOG guideline reinforces a long-standing reality:
we still lack reliable noninvasive diagnostics, and many patients continue to wait years for answers.
At the same time, awareness of endometriosis has grown significantly, with more patients recognizing symptoms and seeking care earlier than in the past.
Put these pieces together, and a pattern emerges:
- the biology is becoming clearer
- patient awareness is increasing
- but the clinical tools to diagnose disease haven’t kept pace
This is a familiar moment in medicine.
In oncology and infectious disease, major advances didn’t come from a single breakthrough.
They came from building the diagnostic infrastructure that allowed physicians to:
- detect disease earlier
- classify it more precisely
- match patients with the right therapies
Endometriosis may now be approaching a similar inflection point.
As our understanding of the biology deepens – and as new diagnostic approaches emerge – we have an opportunity to fundamentally change how this disease is identified and managed.
For millions of patients who still face years of uncertainty, that shift can’t come soon enough.”
Cadenza Bio shared Somer Baburek’s post on LinkedIn, adding:
“Recent progress in endometriosis research reflects a meaningful shift in how the disease is understood and managed, and we appreciate the perspective shared by Somer Baburek and Hera Biotech. It is encouraging to see strong momentum across the field, with advances in biology, increased patient awareness, and a continued focus on improving diagnostics.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 25, 2026, 10:56PMOS Can Affect Much More Than Periods or Fertility – PCOS Awareness Association
-
Jul 25, 2026, 10:42Asma Khalil: Recreational Drug Use During Pregnancy, What Every Expectant Mother Should Know!
-
Jul 25, 2026, 10:40Khalil Faaed: Are Complex Y Chromosome Rearrangements the Missing Link in Unexplained Male Infertility?
-
Jul 25, 2026, 10:38Sean Lauber: Does Transferring a Cleavage or Blastocyst Stage Embryo Affect the Chance of Having a Boy?
-
Jul 25, 2026, 10:33Rokaya Hachicho: The Hidden Cost of Excessive Laser Use During Trophectoderm Biopsy!
-
Jul 25, 2026, 10:31Join the ISUOG Webinar on Late-Evolving Fetal Anomalies – ISUOG
-
Jul 25, 2026, 10:29Waiting Before Clamping the Umbilical Cord Improves Neonatal Outcomes! – RCOG
-
Jul 25, 2026, 10:27Christopher Robinson: The Impact of Body Mass Index on Misoprostol Dosing for Labor Induction!
-
Jul 25, 2026, 10:26Heavy Menstrual Bleeding and Dysmenorrhea in Adolescents – IJGO